Header Logo

Connection

Raid Aljumaily to Carcinoma, Pancreatic Ductal

Back to Details
This is a "connection" page, showing publications Raid Aljumaily has written about Carcinoma, Pancreatic Ductal.
Raid Aljumaily
Connection Strength
0.155
Carcinoma, Pancreatic Ductal
  1. Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC). Invest New Drugs. 2021 02; 39(1):182-192.
    View in: PubMed
    Score: 0.155
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.